Biological Evaluation of 131I- and CF750-Labeled Dmab(scFv)-Fc Antibodies for Xenograft Imaging of CD25-Positive Tumors
Figure 3
Comparison of the binding ability of the Dmab(scFv) antibody, Dmab(scFv)-Fc antibody, and parental antibody daclizumab. Hut102 cells were incubated with the FITC-labeled antibodies at indicated molar concentration, followed by flow cytometric analysis. The positive rate and MFI of the antibodies were compared.
